![](/img/cover-not-exists.png)
Using long-acting β2-agonists safely: What will be the impact of the US Food and Drug Administration's panel recommendations?
Brian A. SmartVolume:
9
Year:
2009
Language:
english
Pages:
5
DOI:
10.1016/s1098-3597(09)80011-2
File:
PDF, 2.52 MB
english, 2009